News Sentiment

DNLI sentiment intelligence

Denali Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 25.68 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 32

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-0.6% over one week, +18.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Wedbush Raises Price Target on Denali Therapeutics to $26 From $20, Keeps Outperform Rating

Market Reaction

Balanced read

50/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -0.6% Price digesting
Trend fit Trend active 18.6% over four weeks
Fair value 29.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 29
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 32
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
Stock Titan 8
simplywall.st 7
MT Newswires 2
TradingView 2
Investing.com 2
GuruFocus 1
GlobeNewswire 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 8
Analyst action 4
Deals and strategy 2
Regulatory and legal 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40